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Abstract	(246	words)	17	
Background:	 Regular	 intense	 endurance	 exercise	 can	 lead	 to	 amenorrhea	 with	 possible	18	
adverse	consequences	for	bone	health.		19	
Objective:	 We	 compared	 whole-body	 and	 regional	 bone	 strength	 and	 skeletal	 muscle	20	
characteristics	 between	 amenorrheic	 (AA:	 n=14)	 and	 eumenorrheic	 (EA:	 n=15)	 elite	 adult	21	
female	long	distance	runners	and	non-athletic	controls	(C:	n=15).		22	
Study	design	and	Participants:	Participants	completed	three-day	food	diaries,	dual	energy	x-23	
ray	 absorptiometry	 (DXA),	 magnetic	 resonance	 imaging	 (MRI),	 peripheral	 quantitative	24	
computed	tomography	(pQCT)	and	isometric	maximal	voluntary	knee	extension	contraction	25	
(MVC).	26	
Results:	 Both	athlete	 groups	had	a	higher	 caloric	 intake	 than	 controls,	with	no	 significant	27	
difference	between	athlete	groups.	DXA	revealed	lower	bone	mineral	density	(BMD)	at	the	28	
trunk,	rib,	pelvis	and	lumbar	spine	in	the	AA	than	EA	and	C.	pQCT	showed	greater	bone	size	29	
in	the	radius	and	tibia	in	EA	and	AA	than	C.	The	radius	and	tibia	of	AA	had	a	larger	endocortical	30	
circumference	than	C.	Tibia	bone	mass	and	moments	of	inertia	(Ix	and	Iy)	were	greater	in	AA	31	
and	 EA	 than	C,	whereas	 in	 the	 radius	 only	 the	 proximal	 Iy	was	 larger	 in	 EA	 than	C.	 Knee	32	
extensor	MVC	did	not	differ	significantly	between	groups.		33	
Conclusions:	 Amenorrheic	 adult	 female	elite	 long-distance	 runners	had	 lower	BMD	 in	 the	34	
trunk,	lumbar	spine,	ribs	and	pelvis	than	eumenorrheic	athletes	and	controls.	The	radius	and	35	
tibia	 bone	 size	 and	 strength	 indicators	 were	 similar	 in	 amenorrheic	 and	 eumenorrheic	36	
athletes,	suggesting	that	long	bones	of	the	limbs	differ	in	their	response	to	amenorrhea	from	37	
bones	in	the	trunk.	38	
Key	words:	eumennorheic,	amenorrheic,	athletes,	endocortical,	periosteal,	muscle.	 	39	
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Introduction	40	
In	 elite	 endurance	 runners	 an	 appropriate	 balance	 between	 training,	 competition	 and	41	
recovery	is	important	to	maximise	performance	and	prevent	overtraining	[1,	2].	When	this	42	
balance	is	lost,	injuries	[2],such	as	stress	fractures,	caused	by	repeated	stresses	on	the	bone	43	
without	appropriate	recovery	times	can	occur	[1,	2].	44	
	45	
The	mechanostat	 theory	 states	 that	bone	adapts	 to	 increased	mechanical	 loading	 (impact	46	
exercise)	 by	 increasing	 bone	 mass,	 size	 and	 strength	 [3-5]	 while	 reduced	 mechanical	47	
deformation	decreases	[3]	bone	mass,	size	and	strength.	In	line	with	the	mechanostat	theory,	48	
indicators	of	bone	strength	are	5-30%	higher	in	post-pubertal	athletes	than	non-athletes	[5-49	
9].	This	suggests	that	physical	activity	is	important	for	the	development	of	high	bone	mass	50	
and	strength,	leading	to	50-80%	reduction	in	fracture	risk	[5].	51	
	52	
Oestrogen	limits	bone	resorption	by	reducing	osteoclast	activity	[10].	This	may	explain	why	a	53	
low	concentration	of	oestrogen,	occurring	in	the	absence	of	menses	[11],	has	a	negative	effect	54	
on	bone	mineral	density	(BMD)	[12]	and	is	associated	with	a	greater	risk	of	bone	stress	injuries	55	
[13-15].	The	prevalence	of	‘athletic	amenorrhea’	or	menstrual	irregularities	amongst	active	56	
young	women	can	be	as	high	as	60%	[14].	The	associated	low	oestrogen	levels	can	diminish,	57	
or	negate,	benefits	of	regular	exercise	on	bone	[6,	16,	17].		58	
	59	
Amenorrhoea	is	one	of	three	features	of	the	‘female	athlete	triad’	that	was	originally	defined	60	
in	 1997	 as	 a	 simultaneous	 occurrence	 of	 amenorrhea,	 inadequate	 food	 intake	 and	 high	61	
training	 volume	 [18]	 that	 all	 have	 a	 negative	 impact	 on	 bone	 health.	 Most	 studies	 that	62	
considered	the	effects	of	amenorrhea	on	bone	used	dual-energy	x-ray	absorptiometry	(DXA)	63	
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(e.g.	 [16,	 17]).	 	 Using	 DXA,	 higher	 BMD	 and	 strength	 indicators	were	 found	 at	 the	 hip	 in	64	
eumenorrheic	 athletes	 than	 controls,	 while	 no	 such	 differences	 were	 seen	 between	65	
amenorrheic	 athletes	 and	 controls	 [16].	 	 Something	 similar	 has	 been	 seen	 with	 high-66	
resolution	peripheral	quantitative	computerised	tomography	(HR-pQCT)	[6,	7].	However,	HR-67	
pQCT	does	not	give	an	indication	of	whole	bone	strength	and	cannot	examine	long	bone	shaft	68	
sites	such	as	the	tibia,	which	is	particularly	prone	to	stress	fracture	injury	in	athletes	[19]	but	69	
has	received	little	attention	in	studies	of	amenorrheic	athletes.	Nevertheless,	these	studies	70	
suggest	 that	 there	 is	 a	deficit	 in	bone	health	 in	 amenorrheic	 adolescent	 athletes	 and	 it	 is	71	
possible	 that	symptoms	are	worse	 in	adult	elite	 level	athletes	due	to	a	 longer	duration	of	72	
amenorrhea	than	in	adolescent	athletes	[20].	73	
	74	
Reduced	muscle	mass,	maximal	force	and	quality	(defined	as	maximal	isometric	force	per	unit	75	
muscle	cross-sectional	area)	could	be	additional	features	of	amenorrhea	that	impact	on	bone	76	
health	due	to	a	reduced	mechanical	stimulus	to	the	bone	[21].		It	remains	to	be	seen	whether	77	
adult	 amenorrheic	 elite	 athletes	have	 low	muscle	mass	 and/or	quality	of	 specific	muscles	78	
associated	with	 low	strength	 in	the	bones	these	muscles	act	upon,	and	whether	 low	bone	79	
strength	is	related	to	a	low	mass	and/or	quality	of	the	muscles	acting	upon	the	corresponding	80	
bone.	Such	relationships	can	be	examined	using	pQCT,	along	with	imaging	and	dynamometry	81	
of	muscle	groups	acting	upon	bone.	82	
	83	
The	 aim	 of	 the	 present	 study	 was	 to	 examine	 the	 interrelationship	 of	 muscle	 and	 bone	84	
characteristics	 in	female,	adult	elite-level	endurance	athletes	affected	by	amenorrhea.	The	85	
primary	hypothesis	was	 that	amenorrheic	athletes	have	 lower	 indicators	of	bone	strength	86	
than	eumenorrheic	athletes	and	controls	 in	body	 segments	with	 lower	direct	exposure	 to	87	
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weight-bearing	impacts,	whilst	these	indicators	will	be	preserved	in	weight-bearing	bones	of	88	
the	amenorrheic	athlete.	89	
	90	
	91	
Materials	and	Methods	92	
Participants	93	
Twenty-nine	 females,	 aged	 17-42	 years,	 were	 recruited	 after	 sending	 out	 a	 poster	 and	94	
participant	information	sheet	to	all	athletes	on	an	England	Athletics	email	database.	Of	those	95	
that	responded,	only	athletes	that	had	represented	their	home	country	within	the	past	two	96	
years	in	1.5-10-km	runs	were	eligible	to	participate	and	grouped	according	to	their	menstrual	97	
cycle	 history.	 All	 non-athletic	 controls	 were	 recruited	 from	 the	 local	 student	 population,	98	
performed	less	than	2	hours	of	physical	activity	per	week	and	did	not	take	part	 in	athletic	99	
competitions.	 Participants	were	 asked	 about	 the	 phase	 of	menstrual	 cycle	 at	 the	 date	 of	100	
testing,	use	of	oral	contraceptive	pills	(OCP),	any	current	medication,	smoking	habits,	age	of	101	
menarche	 and	 alcohol	 consumption.	 Based	 on	 self-reports,	 athletes	 were	 classified	 as	102	
amenorrheic	(AA)	if	they	had	experienced	an	absence	of	menses	for	≥	12	months	in	a	row	103	
within	the	past	12months.	None	of	the	athletes	had	oligomenorrhea	(4-9	cycles	per	year).	104	
Athletes	with	regular	menstrual	cycles	(>	12	in	the	past	year)	were	classed	as	eumenorrheic	105	
(EA).	Controls	(C)	had	regular	menstrual	cycles,	were	recreationally	active,	but	did	not	take	106	
part	in	competitive	sports.	As	the	study	involves	exposure	to	radiation	during	scanning	any	107	
volunteers	were	excluded	 if	 they	were	pregnant	or	 potentially	 pregnant.	 The	Manchester	108	
Metropolitan	 University	 Ethics	 Committee	 approved	 the	 study	 and	 all	 participants	 gave	109	
written	informed	consent.	Table	1	shows	the	participant	characteristics.		110	
	111	
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Experimental	Protocol	112	
Sporting	history	was	obtained	by	questionnaire.	Participants	completed	a	food	diary	on	three	113	
consecutive	days,	specifying	food	and	drink	consumption.	This	was	analysed	using	nutritional	114	
analysis	software	(Diet	Plan	6	software,	Forestfield	Ltd,	Horsham,	UK	and	Nutritics	software,	115	
Nutritics,	Dublin,	Ireland).	Six	food	diaries	were	excluded	(two	from	controls,	one	from	the	EA	116	
and	three	from	the	AA	group)	due	to	incomplete	details	for	accurate	analysis.	The	age-graded	117	
performance	(AGP)	for	the	main	event	was	calculated	using	the	World	Master	Association’s	118	
Age-grading	Calculator:	119	
http://www.howardgrubb.co.uk/athletics/wmalookup06.html.	120	
	121	
DXA	122	
Scans	 (GE	 Medical,	 Lunar	 Prodigy	 Advance,	 version	 encore	 10.50.086)	 were	 taken	 to	123	
determine	whole	body,	lumbar	spine	(L1-4)	and	hip	bone	mineral	density	(BMD),	and	body	124	
fat	and	lean	mass	percentage.	Geometric	properties	of	the	femoral	neck	were	estimated	using	125	
the	advanced	hip	analysis	(AHA)	software	(GE	Medical,	Lunar	Prodigy	Advance,	version	encore	126	
10.50.086).	 This	 calculated	 the	 cross-sectional	 area	 (CSA),	 the	 cross-sectional	 moment	 of	127	
inertia	(CSMI:	an	index	of	structural	rigidity),	the	width	of	the	neck	and	shaft	of	the	femur	and	128	
the	bone	strength	index,	a	ratio	of	estimated	compressive	yield	strength	of	the	femoral	neck	129	
to	 an	 expected	 compressive	 strength	 of	 a	 fall	 onto	 the	 greater	 trochanter	 [17].	 In	 our	130	
laboratory,	the	coefficient	of	variation	for	body,	hip	and	lumbar	spine	scans	(n=8)	is	0.67%,	131	
2.02%	and	0.9%,	respectively.			132	
	133	
pQCT	134	
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Scans	were	acquired	at	the	non-dominant	radius	and	dominant	tibia	with	XCT-2000	and	XCT-135	
3000	pQCT	scanners	(Stratec	Medizintechnik	GmbH,	Pforzheim,	Germany)	according	to	the	136	
manufacturer’s	protocols.	Images	obtained	with	the	two	scanners	were	cross-calibrated	using	137	
functions	 derived	 from	 scans	 of	 different	 density	 regions	 within	 the	 same	manufacturer-138	
provided	phantom	on	each	scanner.	The	dominant	arm	was	identified	as	the	writing	arm,	and	139	
in	 any	 cases	 of	 ambidexterity,	 the	 dominant	 arm	was	 defined	 as	 the	 favoured	 arm	when	140	
playing	racquet	sports.	The	non-dominant	leg	was	defined	as	the	leg	that	was	preferentially	141	
used	for	hopping.	Scans	were	taken	at	4	and	60%	of	the	radius	length,	and	4	and	66%	of	the	142	
tibia	 length,	 where	 0%	 indicates	 the	 most	 distal	 part	 of	 the	 bones.	 Radius	 length	 was	143	
measured	between	the	olecranon	process	and	the	radial	styloid	process.	Tibia	length	was	the	144	
distance	between	the	palpated	medial	knee	joint	cleft	and	medial	malleolus.	145	
	146	
Data	were	exported	using	the	Automated	Analysis	Tools	(Version	6.00).	A	peeling	threshold	147	
of	180	mg·cm-3	was	applied	to	the	epiphyseal	slice.	At	the	diaphyseal	sites,	a	threshold	of	650	148	
mg·cm-3	was	used	to	separate	cortical	bone.		149	
	150	
The	following	parameters	examined	in	the	4%	epiphyseal	slice:	total	bone	area	(Ar.tot,	mm2),	151	
total	 bone	 mineral	 content	 (vBMC.tot,	 mg·mm-1)	 and	 trabecular	 bone	 mineral	 density	152	
(vBMD.tb,	mg·cm-3).	 iaphyseal	 parameters	 examined	were:	 Ar.tot,	 vBMC.tot,	 cortical	 area	153	
(Ar.ct,	mm2),	cortical	density	(vBMD.ct,	mg·cm-3),	cortical	thickness	(Ct.Thder	mm),	periosteal	154	
(PsC,	mm)	and	endocortical	circumference	(EcC,	mm),	antero-posterior	(Ix)	and	mediolateral	155	
(Iy)	moments	of	inertia	representing	bone	bending	stiffness.	Cortical	bone	density	values	were	156	
corrected	 for	 the	 partial	 volume	 effect	 as	 described	 previously	 [22].	 The	 coefficient	 of	157	
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variation	of	the	pQCT	measurements	in	our	laboratory	has	been	reported	elsewhere	[23]	and	158	
was	<0.5%	for	vBMC.tot,	Ar.tot	and	Ar.ct.		159	
	160	
Magnetic	Resonance	Imaging	(MRI)	161	
A	0.25-T	G-scan	MRI	scanner	(Esaote,	Genova,	Italy)	was	used	to	measure	the	volume	of	the	162	
quadriceps	femoris	and	calf	muscles.	Serial	cross	sections	(each	6.3	mm	thick	with	a	50.4-mm	163	
inter-slice	gap)	were	acquired	from	the	lateral	femoral	condyle	to	the	greater	trochanter	for	164	
the	quadriceps	and	from	the	lateral	femoral	condyle	to	the	lateral	malleolus	for	the	calf	using	165	
a	 turbo	 3-D	 T1	 protocol	 [24].	 Cross-sectional	 area	 was	 determined	 using	 Osirix	 software	166	
(Osirix	medical	imaging	software,	Atlanta,	USA).	The	volumes	of	the	muscle	and	femur	bone	167	
were	estimated	as	the	integration	of	volume	from	each	slice	and	inter-slice	gap.		168	
	169	
Muscle	strength	measures	170	
Maximal	voluntary	isometric	knee	extensor	torque	of	the	quadriceps	muscle	was	measured	171	
with	a	custom-built	dynamometer	[25].	Participants	sat	with	hip	and	knee	angles	flexed	at	172	
around	 900	 and	 straps	 fastened	 around	 the	 hip.	 Participants	 performed	 three	 maximum	173	
voluntary	 knee	 extension	 contractions,	 and	 the	 highest	 torque	 presented.	 Force	was	 also	174	
expressed	as	force	per	quadriceps	volume.	175	
	176	
Statistical	Analysis	177	
Statistical	 analysis	was	performed	on	data	normalised	 to	object	 length	or	body	height,	 to	178	
remove	any	variability	caused	by	differences	in	these	factors,	with	SPSSv19	(IBM,	USA).	Data	179	
was	normally	distributed	as	assessed	using	the	Kolmogrov-Smirnov	test.		A	one-way	ANOVA	180	
was	 used	 to	 assess	 any	 significant	 differences	 between	 control,	 amenorrheic	 and	181	
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eumenorrheic	athletes.	To	test	whether	the	radius	and	the	tibia	showed	the	same	differences	182	
from	control	in	amenorrheic	and	eumenorrheic	athletes	we	performed	a	repeated-measures	183	
ANOVA	with	bone	as	within-factor	bone,	and	group	as	between-factor	on	the	data	of	the	bone	184	
parameters	normalised	to	the	corresponding	average	control	values	for	each	bone.	If	a	main	185	
group	 effect	 was	 found,	 a	 post-hoc	 test	 with	 Bonferroni	 correction	 was	 performed	 to	186	
determine	which	groups	differed	from	each	other.	There	were	no	group*bone	interactions.	187	
Differences	between	groups	were	considered	significant	at	p<0.05.	All	data	are	presented	as	188	
mean	±	standard	error	of	the	mean	(SEM).	All	p-values	shown	in	Tables	1-6	are	those	from	189	
post-hoc	tests	with	Bonferroni	correction.	190	
	191	
	192	
Results		193	
Participants	194	
There	were	no	significant	differences	between	groups	in	age	or	height	(Table	1).	Body	mass	195	
and	BMI	were	lower	in	the	athletes	than	the	C	(p<0.05).	Body	mass	of	EA	was	10%	higher	than	196	
that	of	AA	(p=0.029).	Lean	mass	of	EA,	but	not	that	of	AA,	was	higher	than	C	(p=0.015)	and	197	
both	athletic	groups	had	lower	absolute	and	percentage	fat	mass	than	C	(p<0.05).	The	age-198	
graded	performance	of	EA	and	AA	was	within	15%	of	world	record	times,	with	no	significant	199	
difference	between	the	athlete	groups.	Onset	of	menarche	was	later	in	AA	than	C	(p<0.05),	200	
with	no	significant	differences	between	athlete	groups	or	EA	and	C.	Including	the	age	of	onset	201	
of	menarche	as	a	covariate	did	not	change	any	statistical	results	and	so	was	not	included	in	202	
final	analysis	(data	not	shown). 203	
	204	
Food	Diaries	205	
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Total	 daily	 energy	 (kJ·day-1) intake	 was	 less	 in	 C	 than	 athlete	 groups	 (both	 p<0.05;	 C;	206	
6217±659,	EA;	10567±880,	AA;	9723±748).		207	
	208	
Muscle	size	and	knee	extensor	strength	209	
Table	2	 shows	 that	 there	was	no	 significant	difference	 in	 forearm	and	 tibia	muscle	 cross-210	
sectional	 area,	 and	 calf	 and	quadriceps	muscle	 volume	between	any	groups.	Both	athlete	211	
groups	had	greater	maximal	 voluntary	 knee	extension	 torque	 than	C	 (p<0.045),	 (Table	2).	212	
Femur	volume	was	higher	in	the	athlete	groups	than	C	(p<0.05),	but	did	not	differ	significantly	213	
between	EA	and	AA	(Table	2).		214	
	215	
	216	
DXA	217	
Total	body,	arms	and	hip	BMD	did	not	differ	significantly	between	groups	(Table	3).	Trunk,	218	
rib,	lumbar	spine	and	pelvis	BMD	were	lower	in	AA	than	EA	and	C	(all	p<0.05).	Leg	BMD	was	219	
significantly	greater	in	EA	than	C	(p<0.05),	with	no	significant	difference	between	AA	and	C	220	
(Table	3).	221	
	222	
Hip	structure	of	the	femurs	was	similar	for	both	athlete	groups	(Table	4).	Cortical	width	of	the	223	
femur	shaft	was	greater	in	both	athletes	than	C	(p<0.05).	There	was	no	significant	difference	224	
between	 any	 groups	 in	 the	 cortical	 width,	 cross-sectional	 area	 of	 the	 femur	 neck,	 bone	225	
strength	index	or	cross-sectional	moment	of	inertia.	226	
	227	
pQCT	228	
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Table	5	shows	pQCT	radius	data.	At	the	epiphyseal	site	the	total	bone	area	of	the	radius	(Ar.tot)	229	
of	both	athlete	groups	was	greater	than	C	(p<0.05).	Total	bone	mineral	content	(vBMC.tot),	230	
trabecular	bone	mineral	density	(vBMD.tb)	and	bone	strength	index	of	the	radius	epiphysis	231	
showed	no	significant	differences	between	groups.	232	
	233	
At	the	diaphysis	site	of	the	radius,	total	area	was	larger	 in	EA	and	AA	than	C(p<0.004),	but	234	
there	were	no	significant	differences	between	groups	 in	cortical	bone	mineral	content	and	235	
density	(Table	5).	236	
	237	
The	periosteal	circumference	was	larger	in	the	athletes	than	the	C	(p≤0.01;	Figure	1A).		The	238	
moment	of	 inertia	was	 significantly	 greater	 in	EA	 than	C	 in	 the	y	plane,	but	 there	was	no	239	
significant	difference	between	any	groups	in	the	x	plane	(Table	5).	240	
	241	
Table	6	shows	pQCT	tibia	data.	Total	bone	mineral	content	for	the	epiphysis	of	the	tibia	was	242	
greater	in	EA	than	C	(p<0.05),	with	no	significant	difference	between	athlete	groups	or	AA	and	243	
C.	Trabecular	BMD	and	total	area	of	the	tibia	epiphysis	was	greater	in	both	athlete	groups	than	244	
C	(p<0.05),	with	no	significant	difference	in	bone	strength	index	between	groups.	245	
	246	
Total	area	and	total	bone	mineral	content	at	the	tibia	diaphysis	were	larger	in	the	AA	and	EA	247	
than	C	(p<0.05).	The	trabecular	BMD	of	the	diaphysis	was	greater	in	C	than	AA	(p=0.02)	and	248	
EA	(p<0.0005).	The	moment	of	inertia	in	the	y-	and	x-plane	at	the	tibia	diaphysis	was	greater	249	
in	the	athletes	than	the	C	(p<0.05;	Table	6).	250	
	251	
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For	 the	 diaphysis	 of	 both	 the	 radius	 and	 the	 tibia	 the	 cortical	 thickness	 did	 not	 differ	252	
significantly	 between	 groups	 (Figure	 1B),	 but	 the	 cortical	 area	 was	 larger	 in	 EA	 than	 C	253	
(p=0.005;	Figure	1C).	The	endocortical	circumference	(Figure	1D)	was	~20%	greater	in	AA	than	254	
C	(p=0.001),	with	no	significant	difference	between	C	and	EA,	or	EA	and	AA.	These	changes	255	
are	illustrated	in	figure	2.		256	
	257	
Discussion	258	
The	main	observations	of	 the	 study	are	 that	amenorrheic	adult	 female	elite	 long-distance	259	
runners	have	a	lower	bone	mineral	density	in	the	trunk,	lumbar	spine,	ribs	and	pelvis	than	260	
eumenorrheic	athletes	and	controls.	In	contrast,	tibia	cortical	bone	strength	indicators	were	261	
greater	in	both	athlete	groups	than	controls	but	no	such	difference	was	seen	in	the	radius.	262	
This	suggests	that	long	bones	differ	in	their	response	to	amenorrhea	from	bones	in	the	trunk.	263	
Similar	to	eumonerrheic	athletes,	the	amenorrheic	athletes	had	a	larger	and	stronger	tibia	264	
and	 femur	 than	 controls	 indicating	 that	 the	 bone	 response	 to	 regular	 loading	 is	 not	265	
attenuated	by	amenorrhea.	Yet,	it	is	unlikely	that	loading	can	normalise	bone	remodelling	in	266	
amenorrheic	athletes	entirely	as	both	the	unloaded	radius	and	the	loaded	tibia	exhibited	an	267	
increase	in	endocortical	circumference.	268	
	269	
Study	participants	270	
The	long-distance	runners	in	the	present	study	had	represented	their	country	at	international	271	
athletic	events.	The	average	age-graded	performance	for	both	athlete	groups	was	85%;	for	a	272	
26-year-old	female	this	equates	to	35	mins	for	10	km	and	2	hours	40	mins	for	a	marathon.	273	
This	 confirmed	 that	 the	 recruited	 athletes	 were	 indeed	 elite	 athletes.	 The	 athletes	 were	274	
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classified	 as	 amenorrheic	 if	 they	 self-reported	 an	 absence	 of	 menses	 for	 at	 least	 12	275	
consecutive	months	 in	a	 row.	 In	addition,	none	of	 the	athletes	were	oligomenorrheic,	 the	276	
average	duration	of	amenorrhea	in	the	AA	was	5.5	years	and	the	EA	athletes	were	on	average	277	
12	years	eumenorrheic,	indicating	that	the	EA	and	AA	athletes	represented	distinct	groups.	278	
The	self-reported	method	to	characterise	amenorrhea	 is	preferred	to	measurement	of	sex	279	
hormones,	which	are	subject	to	fluctuations	during	the	menstrual	cycle	and	diurnal	variations	280	
[26].	281	
		282	
Energy	balance	283	
Persistent	energy	deficiency,	occurring	in	up	to	62%	of	elite	female	athletes,	is	considered	an	284	
important	cause	of	irregular	or	absent	menstruation	[18],	both	of	which	can	lead	to	reduced	285	
bone	 health	 [20].	 The	 common	 co-occurrence	 of	 amenorrhea	 and	 energy	 deficiency	 in	286	
athletes	has	made	it	difficult	to	disentangle	the	effects	of	amenorrhea	and	energy	deficiency	287	
in	previous	studies	[27].	In	our	study,	the	AA	and	EA	reported	similar	total	energy	intake	that	288	
exceeded	that	of	the	non-athletes	by	more	than	30%,	suggesting	that	energy	deficit	is	unlikely	289	
to	be	the	cause	of	bone	differences	between	athletes	and	controls,	or	AA	and	EA,	within	our	290	
sample.	291	
	292	
Muscle	mass	and	function	293	
According	 to	 the	 mechanostat	 theory	 [4],	 mechanical	 strain	 on	 bone,	 caused	 by	 muscle	294	
contraction,	 stimulates	 bone	 formation	 and	 increases	 bone	 strength	 [3,	 4].	 Effects	 of	295	
amenorrhea	may	thus	be	secondary	to	muscle	weakness	or	a	loss	of	muscle	mass.	We	do	not	296	
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think	 low	muscle	mass	or	weakness	was	a	major	consideration	in	our	study	because	there	297	
were	 no	 significant	 differences	 in	 muscle	 mass	 and	 maximal	 strength	 between	 the	298	
eumenorrheic	and	amenorrheic	athletes,	although	we	did	not	determine	the	muscle	forces	299	
during	running	and	therefore	cannot	entirely	rule	out	any	differences	between	groups	in	the	300	
mechanical	strain	on	bones	during	training.	301	
	302	
Non-weight-bearing	bones		303	
The	torso,	lumbar	spine,	rib	and	hips	of	amenorrheic	athletes	had	a	lower	BMD	than	those	of	304	
the	eumenorrheic	athletes	and	controls.	Bone	area	was	also	 lower	at	these	sites,	and	as	a	305	
result	amenorrheic	athletes	had	large	deficits	in	bone	mineral	content	compared	to	the	other	306	
two	groups	(data	not	shown).	As	these	bones	are	not	loaded	during	running,	due	to	impact	307	
damping	and	limited	direct	contribution	of	the	surrounding	muscles	to	locomotion,	it	could	308	
be	argued	that	the	detrimental	impact	of	amenorrhea	on	these	bones	is	not	compensated	by	309	
the	osteogenic	effect	of	increased	loading.	Previous	studies	reported	lower	trabecular	bone	310	
mineral	density	at	the	epiphysis	of	the	radius	in	amenorrheic	than	eumenorrheic	athletes	and	311	
controls	 [6].	 However	 in	 the	 current	 study	 it	 was	 observed	 that	 in	 contrast	 to	 the	 trunk	312	
skeleton,	in	the	radius	the	bone	mineral	density	was	similar,	and	not	less,	in	amenorrheic	than	313	
eumenorrheic	 athletes	 and	 controls.	 Such	a	difference	between	bones	 in	 the	 response	 to	314	
amenorrhea	has	been	observed	previously;	where	bone	mineral	 density	was	 lower	 in	 the	315	
lumbar	vertebrae,	but	not	in	the	radius	and	the	femur	[28].	It	has	been	suggested	that	the	316	
loss	of	bone	mineral	density	in	the	lumbar	vertebrae	is	due	to	loss	of	body	mass	rather	than	317	
amenorrhea	 per	 se	 [29].	 This	 indeed	 corresponds	 with	 the	 lower	 body	 mass	 of	 the	318	
amenorrheic	 athletes,	 but	 is	 at	 odds	 with	 the	 similar	 bone	 mineral	 density	 in	 the	 trunk	319	
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skeleton	of	eumenorrheic	athletes	and	controls	despite	the	lower	body	mass	of	the	athletes.	320	
Also,	in	the	radius,	a	lower	body	mass	does	not	explain	the	absence	of	a	lower	bone	mineral	321	
density	in	the	the	amenorrheic	athletes.	We	speculate	that	the	best	explanation	for	the	lower	322	
bone	mineral	density	 in	the	trunk	skeleton,	but	maintained	radius	bone	mineral	density	 in	323	
amenorrheic	athletes,	 is	that	long	bones	and	the	bones	in	the	trunk	respond	differently	to	324	
amenorrhea.	 Indeed,	 there	 are	 some	 indications	 in	 rat	 models	 that	 the	 responses	 to	325	
oestrogen	on	bone	are	site-specific	[30],	but	this	requires	further	investigation.	326	
	327	
Weight-bearing	bones	328	
In	the	femur,	bone	CSA	and	the	cortical	width	of	the	shaft	were	larger	in	both	athlete	groups	329	
than	controls.	This	is	consistent	with	previous	observations	[31]	suggesting	that	the	effects	of	330	
loading	are	not	attenuated	in	those	with	amenorrhea.	Others	have	reported	lower	bone	size	331	
and	strength	in	amenorrheic	compared	to	eumenorrheic	athletes	[32].	Part	of	the	discrepancy	332	
may	be	related	to	the	younger	age	of	the	athletes	in	previous	studies.	For	 instance,	 in	one	333	
study	the	average	age	was	20	[33]	and	in	another	only	17	years	[31],	compared	to	the	26	years	334	
in	our	study,	the	age	at	which	females	have	reached	their	maximum	bone	strength	[34].	335	
	336	
Although	the	tibia	is	a	common	stress	fracture	site	in	athletes,	tibial	diaphysis	strength	has	337	
been	ignored	in	previous	pQCT	research	involving	amenorrheic	and	eumenorrheic	athletes.	338	
In	a	monozygotic	twin	study	it	was	found	that	regular	physical	activity	resulted	in	an	increase	339	
in	BMD	in	the	epiphysis	of	the	tibia	only	[35].	This	is	similar	to	the	larger	BMD	in	the	epiphysis,	340	
but	not	diaphysis,	in	the	athletes	than	controls	in	our	study	and	supports	the	notion	that	bone	341	
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adaptations	 to	 exercise	may	 be	 site-specific	 [35].	 Nevertheless,	 we	 found	 that	 bone	 size,	342	
strength	and	cortical	bone	area	of	the	diaphysis	was	larger	in	athletes	than	controls,	with	no	343	
significant	differences	between	amenorrheic	and	eumenorrheic	athletes,	except	for	the	larger	344	
epiphyseal	 bone	 strength	 (indicated	 by	 total	 bone	 mass)	 over	 controls	 in	 eumenorrheic	345	
athletes	 only.	 This,	 similar	 to	 the	 observations	 in	 the	 femur,	 indicates	 that	 the	 effects	 of	346	
regular	loading	on	bone	[9,	36]	are	not	attenuated	by	amenorrhea.	347	
	348	
Bone	remodelling	349	
In	both	the	radius	and	the	tibia	the	endocortical	circumference	were	larger	in	amenorrheic	350	
athletes	 than	 non-athletes,	 suggesting	 endocortical	 expansion	 (resorption)	 that	 could	 be	351	
attributable	to	their	lack	of	oestrogen	[37].	At	the	same	time,	both	the	radius	and	tibia	had	352	
expanded.	These	findings	are	similar	to	that	previously	suggested	by	Mikkola	et	al	[38],	in	that	353	
the	effect	of	oestrogen	is	systemic	with	the	tibia	and	radius	being	affected	similarly.	This	effect	354	
also	has	some	similarity	to	the	decline	in	trabecular	BMD	[39]	and	increase	in	bone	size	[40]	355	
during	 pregnancy.	 This	 pregnancy-induced	 loss	 of	 BMD	 can	 be	 recovered	 during	 lactation	356	
when	the	child	is	weaned	[39,	40]	and	if	the	underlying	cause	is	similar,	the	expansion	of	the	357	
endocortical	 circumference	 in	 the	amenorrheic	 athletes	 could	most	 likely	be	 recovered	by	358	
normalisation	of	the	menstrual	cycle.	In	a	study	of	monozygotic	twins,	hormone	replacement	359	
therapy	(HRT)	was	associated	with	larger	cortical	bone	areas	and	smaller	endocortical	areas	360	
[38].	 It	 is	 not	 known,	 however,	 if	 this	 would	 be	 effective	 in	 amenorrheic	 athletes	 as	 the	361	
duration	of	HRT	 in	 the	 twins	 study	was	on	average	8	years.	Although	 regular	exercise	was	362	
associated	 with	 a	 smaller	 endocortical	 area	 in	 monozygotic	 twins	 [35]	 it	 is	 unlikely	 that	363	
normalisation	of	the	endocortical	circumference	in	amenorrheic	athletes	can	be	realised	by	364	
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increased	loading,	as	both	the	unloaded	radius	and	the	loaded	tibia	exhibit	this	increase	in	365	
endocortical	circumference.	366	
	367	
Limitations	368	
It	was	 not	 possible	 to	 include	 energy-deficient	 amenorrheic	 athletes	 in	 the	 current	 study,	369	
which	may	have	offered	further	insights.	However,	this	might	equally	be	seen	as	a	strength	of	370	
our	 study	 because	we	were	 able	 to	 rule	 out	 the	 contribution	 of	 energy	 deficiency	 to	 our	371	
observations.	 Circulating	 levels	 of	 oestrogen	 were	 not	 measured	 which	 may	 have	372	
complemented	the	assessment	of	amenorrhea.	However,	oestrogen	levels	vary	considerably	373	
during	 the	 menstrual	 cycle	 and	 diurnally,	 complicating	 distinction	 of	 eumonorrheic	 and	374	
amenorrheic	athletes.	Five	of	the	athletes	stated	they	were	taking	the	oral	contraceptive	pill	375	
(OCP)	for	contraceptive	reasons	only.	One	AA	who	took	OCP	still	suffered	from	amenorrhea	376	
and	her	 bone	parameters	were	 all	within	 the	 range	of	 the	 group.	 The	 EA	 athletes	 all	 had	377	
regular	cycles	prior	to	using	OCP	and	given	these	observations,	we	expect	that	OCP	had	no	378	
significant	impact	on	our	findings.	379	
	380	
Perspective	381	
The	lower	bone	strength	indicators	in	bones	of	the	trunk	but	not	the	radius	of	amenorrheic	382	
athletes	 is	 not	 entirely	 explained	 by	 reduced	 loading,	 but	 rather	 suggests	 that	 the	 bone	383	
response	to	amenorrhea	is	site-specific.	While	the	strength	of	weight	bearing	bones	in	the	EA	384	
and	AA	are	similar,	the	enlargement	of	the	endocortical	area,	similar	to	that	shown	by	Mikkola	385	
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et	al	[38],	cannot	be	reversed	by	loading.	We	speculate	that	this	can	only	be	normalised	by	a	386	
return	to	a	normal	menstrual	cycle.	387	
	388	
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483	
Figure	1:	A)	Periosteal	circumference	(mm)	for	the	radius	diaphysis	(RD)	and	tibia	diaphysis	484	
(TD)	adjusted	for	object	length;	B)	Cortical	Thickness	(mm)	for	the	radius	diaphysis	(RD)	and	485	
tibia	diaphysis	(TD)	adjusted	for	object	length;	C)	Cortical	Area	(mm2)	for	the	radius	diaphysis	486	
(RD)	and	the	tibia	diaphysis	(TD)	adjusted	for	object	length;	D)	Endocortical	Circumference	487	
(mm)	for	the	radius	diaphysis	(RD)	and	the	tibia	diaphysis	(TD)	adjusted	for	object	length.	C:	488	
controls,	EA:	eumenorrheic	athletes,	AA:	amenorrheic	athletes.	a:	Significantly	different	from	489	
controls.	490	
	491	
	492	
	493	
	494	
22	|	P a g e 	
	
	495	
Figure	2:	A	Schematic	diagram	to	show	the	difference	between	groups	in	the	endocortical	496	
circumference	(EC)	and	Periosteal	Circumference	(PeriC).	AA	have	a	significantly	greater	497	
circumferences’	than	both	EA	and	controls	with	no	difference	between	EA	and	controls.	498	
*=significantly	different	to	controls;	§=significantly	different	to	EA.		499	
	500	
	501	
	502	
	503	
	504	
	505	
	506	
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	507	
Table	1.	Characteristics	of	controls	(C),	and	eumenorrheic	(EA)	and	amenorrheic	athletes	(AA). 	508	
	 C	
N=15	
EA	
N=15	
AA	
N=14	
P	VALUE	
C	VS.	AA	
P	
VALUE	
C	VS.	EA	
P	VALUE	
AA	VS.	EA	
Age	(Years)	 26.8±0.9	 27.6±2.1	 26.4±0.8	 0.863	 0.714	 0.594	
Height	(m)	 1.66±0.17	 1.66±0.02	 1.64±0.02	 0.590	 0.862	 0.479	
Mass	(kg)	 59.6±1.5	 54.5±1.3	 49.6±1.6	 <0.0005	 0.037	 0.029	
BMI	(kg·m-2)	 21.7±0.6	 19.8±0.4	 18.3±0.4	 <0.0005	 0.009	 0.045	
Lean	mass	(kg)	 39.0±1.6	 44.5±1.1	 42.0±1.2	 0.112	 0.015	 0.215	
Fat	mass	(kg)	 18.5±1.5	 8.1±0.7	 5.3±0.6	 <0.0005	 <0.0005	 0.054	
Body	fat	mass	(%)	 30.6±2.1	 14.9±1.2	 10.7±1.0	 <0.0005	 <0.0005	 0.065	
Lean	mass	(%)	 65.4±2.2	 82.4±1.2	 86.8±1.1	 <0.0005	 <0.0005	 0.059	
AGP	(%)	 N/A	 86.9±1.0	 86.6±1.2	 N/A	 N/A	 0.890	
Age	of	menarche		
(years)	
13.0±0.34	 14.1±0.35	 14.9±0.54	 0.01	 0.051	 0.275	
Data	are	presented	as	mean	±	SEM.	AGP:	Age-graded	performance.	509	
	510	
	511	
	512	
	513	
	514	
	515	
	516	
	517	
	518	
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Table	2.	Muscle	size	and	strength	and	femur	size	in	controls	(C),	eumenorrheic	athletes	(EA)	519	
and	amenorrheic	athletes	(AA)	as	determined	with	MRI.	520	
	521	
Data	are	presented	as	mean	±	SEM.	P-values	reflect	those	related	to	the	data	adjusted	for	522	
Femur	length	in	leg	measures	and	radius	length	for	forearm	measures.	523	
	 	524	
	 C	 EA	 AA	 P	VALUE	
	 n=15	 n=15	 n=14	 C	vs.	
AA	
C	vs.	
EA	
AA	vs.	
EA	
Forearm	Muscle	CSA	(mm2)	 2617±93	 2637±94	 2516±101	 0.555	 0.876	 0.458	
Lower	Leg	Muscle	CSA	
(mm
2
)	
6457±221	 7002±193	 7099±242	 0.225	 0.944	 0.198	
Calf	Volume	(cm³)	 1316±70	 1317±74	 1325±86	 0.670	 0.556	 0.884	
Quadriceps	Volume	(cm³)	 1239±89	 1469±92	 1461±80	 0.146	 0.157	 0.951	
Quadriceps	Strength	(Nm)	 171±6	 164±7	 163±10	 0.314	 0.304	 0.992	
Normalised	Force	(Nm.cm¯³)	 0.141±0.008	 0.115±0.007	 0.117±0.007	 0.045	 0.035	 0.921	
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Table	3.	Bone	mineral	density	as	obtained	with	DXA	data	for	controls	(C)	and	eummenhoreic	525	
(EA)	and	ammenorheic	athletes	(AA).	526	
	 C	 EA	 AA	 P	VALUE	(AD	FOR	BODY	HEIGHT)	
	 n=15	 n	=15	 n=14	 C	vs.	AA	 C	vs.	EA	 AA	vs.	EA	
Total	(g·cm-2)	 1.17±0.02	 1.19±0.01	 1.13±0.03	 0.318	 0.365	 0.064	
Arms	(g·cm-2)	 0.82±0.01	 0.83±0.01	 0.81±0.03	 0.715	 0.575	 0.364	
Average	Hip	(g·cm-2)	 1.06±0.04	 1.12±0.03	 1.02±0.04	 0.435	 0.302	 0.078	
Trunk	(g·cm-2)	 0.91±0.03	 0.91±0.02	 0.82±0.02	 0.002	 0.909	 0.003	
Ribs	(g·cm-2)	 0.68±0.02	 0.65±0.02	 0.62±0.01	 0.005	 0.100	 0.198	
Spine	L1-4	(g·cm-2)	 1.19±0.03	 1.16±0.03	 1.04±0.04	 0.004	 0.585	 0.015	
Pelvis	(g·cm-2)	 1.11±0.01	 1.14±0.02	 0.99±0.03	 0.004	 0.568	 0.001	
Legs	(g·cm-2)	 1.25±0.03	 1.33±0.02		 1.26±0.03	 0.555	 0.032	 0.122	
	527	
Data	are	presented	as	mean	± SEM.	528	
	 	529	
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Table	4.	Hip	and	femur	structural	characteristics	for	controls	(C)	and	eummenhoreic	(EA)	and	530	
ammenorheic	athletes	(AA).	531	
	 								C	 EA	 AA	 p	value	(ad	for	FL)	
	 	
n=15	
	
n=15	
	
n=14	
	
C	vs.	AA	
	
C	vs.	EA	
	
AA	vs.	EA	
Cortical	width	shaft	(mm)	 3.73±0.33	 5.68±0.41	 4.89±0.43	 0.034	 0.001	 0.182	
Cortical	width	neck	(mm)	 6.16±0.59	 7.20±0.50	 6.89±0.40	 0.411	 0.198	 0.642	
CSA	femoral	neck	(mm2)	 146±7.9	 158±4.7	 146±5.7	 0.698	 0.255	 0.134	
Strength	Index	(BSI)	 1.69±0.10	 1.81±0.07	 1.89±0.11	 0.161	 0.398	 0.570	
CSMI	(mm4)	 9645±601	 9840±676	 8645±524	 0.056	 0.847	 0.086	
Femur	CSA	(cm²)	 10.5±1.1	 16.4±0.9		 15.9±2.0		 0.013	 0.005	 0.788	
Femur	Volume	(cm³)	 56.6±6.2	 88.4±5.1		 85.5±10.8		 0.012	 0.005	 0.769	
	532	
Data	are	presented	as	mean	±	SEM.	Cross-sectional	moment	of	inertia	(CSMI),	cross-sectional	533	
area	(CSA)	of	the	femur	neck.	P	values	displayed	for	data	adjusted	for	femur	length	(FL).	534	
	 	535	
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Table	5.	Peripheral	quantitative	computer	tomography	(pQCT)	data	for	the	Radius	epiphysis	536	
(RE,	 4%)	 and	 Radius	 diaphysis	 (RD,	 60%)	 in	 controls	 (C),	 and	 eumenorrheic	 (EA)	 and	537	
amenorrheic	athletes	(AA).	538	
	539	
	540	
	541	
RE:	Radius	epiphysis;	RD:	Radius	diaphysis;	vBMDct	(mg·mm-³):	Cortical	bone	mineral	density;	542	
vBMDtb	 (mgmm-³):	 Trabecular	 bone	mineral	 density;	 Artot	 (mm²);	 Arct	 (mm²):	 Cortical	543	
Area:	EcC	(mm):	Endochondral	circumference;	Iy	and	Ix,	(mm4):	moment	of	inertia	indicating	544	
bone’s	 Stiffness	 in	 bending	 perpendicular	 to	 line	 of	 flexion/extension,	 in	 line	 with	545	
flexion/extension	and	torsion	respectively.	Data	are	presented	as	mean	±	SEM.	546	
	547	
	548	
	549	
	 C	 EA	 AA	 P	VALUE	(AD	FOR	RADIUS	LENGTH)	
	 n=15	 n=15	 n=14	 C	vs.	AA	 C	vs.	EA	 AA	vs.	EA	
RE	Ar.tot	(mm2)	 319±14	 367±14	 365±15	 0.035	 0.023	 0.931	
RE	vBMC.tot	(mg.mm-¹)	 101±4	 109±4	 102±6	 0.861	 0.220	 0.304	
RE	vBMD.tb	(mg.mm-³)	 186±9	 197±11	 197±15	 0.604	 0.576	 0.984	
RD	Ar.tot	(mm2)	 102±4	 111±3	 112±4	 0.034	 0.045	 0.839	
RD	vBMC.tot	(mg.mm-1)	 93.0±4.0	 103.2±4.0	 98.9±4.3	 0.997	 0.336	 0.529	
RD	vBMDct	(mg.mm-3)	 1132±14	 1144±8	 1142±11	 0.819	 0.721	 0.907	
RD	Iy	(mm
4
)	 138±7	 158±7	 156±7	 0.067	 0.032	 0.801	
RD	Ix	(mm
4
)	 135±8	 149±8	 151±8	 0.165	 0.190	 0.896	
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Table	6.	Peripheral	quantitative	computer	tomography	(pQCT)	data	 for	the	Tibia	epiphysis	550	
(TE,	4%)	and	Tibia	diaphysis	(TD,	66%)	in	controls	(C),	and	eumenorrheic	(EA)	and	amenorrheic	551	
athletes	(AA).	552	
	553	
	 C	 EA	 AA	 P	VALUE	(AD	FOR	TIBIA	LENTGH)	
	 n=15	 n=15	 n=14	 C	vs.	AA	 C	vs.	EA	 AA	vs.	EA	
TE	vBMC.tot	(mg·mm-¹)	 296±11	 337±11	 324±12	 0.147	 0.012	 0.858	
TE	vBMD.tb	(mg·mm-³)	 232±12	 263±10	 265±10	 0.024	 0.028	 0.091	
TE	Ar.tot	(mm²)	 977±36	 1067±32	 1056±34	 0.032	 0.032	 0.437	
TD	Ar.tot	(mm2)	 436±17	 500±11	 522±22	 <0.0005	 0.004	 0.213	
TD	vBMC.tot	(mg·mm-¹)	 312±9	 390±8	 364±10	 0.006	 <0.0005	 0.153	
TD	vBMD.ct	(mg·mm-3)	 1127±7	 1122±7	 1112±8	 0.02	 <0.0005	 0.280	
TD	Ix	(mm
4
)	 1288±58	 1580±60	 1696±63	 <0.0005	 0.001	 0.237	
TD	Iy	(mm
4
)	 863±41	 1077±43	 1071±45	 0.004	 <0.0005	 0.599	
	554	
TE:	 Tibia	epiphysis;	 TD:	Tibia	diaphysis;	 vBMDct	 (mg·mm-³):	Cortical	bone	mineral	density;	555	
vBMDtb	 (mgmm-³):	 Trabecular	 bone	mineral	 density;	 Artot	 (mm²);	 Arct	 (mm²):	 Cortical	556	
Area:	EcC	(mm):	Endochondral	circumference;	Iy	and	Ix,	(mm4):	moment	of	inertia	indicating	557	
bone’s	 stiffness	 in	 bending	 perpendicular	 to	 line	 of	 flexion/extension,	 in	 line	 with	558	
flexion/extension	and	torsion	respectively.	Data	are	presented	as	mean	±	SEM.	559	
	 	560	
29	|	P a g e 	
	
	 	561	
30	|	P a g e 	
	
	562	
	563	
	564	
	565	
	566	
	567	
	568	
	569	
	570	
	571	
	572	
	 	573	
31	|	P a g e 	
	
	574	
